07:16 AM EST, 03/03/2025 (MT Newswires) -- Syndax Pharmaceuticals ( SNDX ) reported a Q4 net loss Monday of $1.10 per diluted share, wider than a loss of $1 a year earlier.

Analysts polled by FactSet expected a loss of $0.84.

Revenue for the quarter ended Dec. 31 was $7.7 million.

Analysts surveyed by FactSet expected $35.1 million.

As of Dec. 31, Syndax said its cash, cash equivalents, and short and long-term investments were $692.4 million.

Its shares were down 4% in recent premarket activity.